|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-9-4
|
|
pubmed:abstractText |
To determine the clinical activity and safety of the combination immunotherapy of the chimeric anti-CD20 antibody, Rituximab, and Interferon (IFN)- alpha 2a
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
pubmed-author:BaldiniLL,
pubmed-author:BoccominiCC,
pubmed-author:BrugiatelliMM,
pubmed-author:DastoliGG,
pubmed-author:Di RaimondoFF,
pubmed-author:FedericoMM,
pubmed-author:LisoVV,
pubmed-author:MerloLL,
pubmed-author:PazJ AJA,
pubmed-author:PetriniMM,
pubmed-author:RupoliSS,
pubmed-author:SacchiSS,
pubmed-author:SaglioGG,
pubmed-author:TabilioAA,
pubmed-author:VallisaDD,
pubmed-author:VinciGG,
pubmed-author:VitoloUU
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
951-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11532623-Adult,
pubmed-meshheading:11532623-Aged,
pubmed-meshheading:11532623-Antibodies, Monoclonal,
pubmed-meshheading:11532623-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:11532623-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11532623-Female,
pubmed-meshheading:11532623-Humans,
pubmed-meshheading:11532623-Interferon-alpha,
pubmed-meshheading:11532623-Italy,
pubmed-meshheading:11532623-Lymphoma, Non-Hodgkin,
pubmed-meshheading:11532623-Male,
pubmed-meshheading:11532623-Middle Aged,
pubmed-meshheading:11532623-Recombinant Proteins,
pubmed-meshheading:11532623-Recurrence,
pubmed-meshheading:11532623-Safety,
pubmed-meshheading:11532623-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma.
|
|
pubmed:affiliation |
Dipartimento di Scienze Mediche, Oncologiche e Radiologiche, Università de Modena, Italy. ssacchi@unimo.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
